Insider selling
Traded Nov 10 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −5.6% · S&P 500 −2.6% · to Nov 18
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
HCA · NYSE · Health Care Facilities
HCA Healthcare (HCA) · oqro.io/stocks/HCA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Baskets of the companies that insiders, members of Congress or funds recently reported buying, each held under a written rule.
No open-market purchase by an insider of HCA Healthcare was filed in the last 90 days. The latest on record was on Mar 28, 2025.
Since 2004, HCA Healthcare insiders reported 95 open-market purchases and 819 sales on Forms 4 and 5, with purchases in 9 different years, most recently 2022.
In the last 90 days, 3 insiders of HCA Healthcare (HCA) reported 10 open-market sales worth $18.3M in total on SEC Form 4. The largest seller by value was Jon M Foster, with $15.9M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Yes. Members of Congress disclosed 3 trades in HCA Healthcare (HCA) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Rep. Jared Moskowitz (FL23), Sen. Alan Armstrong.
HCA Healthcare's next results are expected on Jan 25, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$476.35−24.84 (−4.96%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
−0.4% (−$1.79) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $478.14 on Nov 18, 2025 to $476.35 on Nov 18, 2026 (−0.4%). Disclosed in this range: 22 insider trades, 0 pre-arranged insider sales, 3 Congress trades, and 99 13F position changes for 3 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Facilities company based in Nashville, Tennessee.
Last 12 months
−0.4%
Market value
$99.5B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 4.8M shares sold short (2.3% of shares outstanding), −2.1% vs the previous count, 3.3 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$19.8B
+3.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$5.97B
This quarter $3.1B, a year earlier $3.13B
Net debt
$43.9B
Debt $44.8B, cash $908M, at Sep 30, 2026
Net income, last 12 months
$6.78B
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 27, 2026.
Revenue, fiscal 2025
$75.6B
+7.1% vs the year before
Net income, fiscal 2025
$6.78B
As reported in the annual filing
Shares outstanding
209M
As of Oct 26, 2026
In fiscal 2025 the company spent $10.1B buying back its own shares and $679M on dividends. Cash actually paid, from its cash-flow statement.
Next ex-dividend date Dec 15, 2026: $0.78 a share (quarterly), payable Dec 29, 2026. Calendar
Insider selling
Traded Nov 10 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −5.6% · S&P 500 −2.6% · to Nov 18
HCA Healthcare's SVP & Chief Nurse Executive sold $1.77M of HCA Healthcare shares. The filing does not indicate a pre-arranged trading plan.
Erica Rossitto (Officer) plans to sell ~$1.77M of HCA Healthcare
Planned, from payFund moves
An amended Schedule 13D: the activist holder's stake changed by at least half a point.
Traded Nov 4 – Nov 6, 2026 · largest single transaction ~$5.14MNot reported under a pre-arranged trading plan
Nov 4, 2026~$5.14M · 10K sh @ $514.07
DetailsOfficial recordNov 6, 2026~$3.76M · 7,595 sh @ $494.91
DetailsOfficial recordPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
On the public record for HCA Healthcare over the 12 months to Nov 18, 2026: 28 executive contributions.
Written by software from the filings listed below · Nov 13, 2026
4 more points, with the facts they come from, are in OQRO Pro.
Sign up freeInsiders of HCA Healthcare reported 95 open-market purchases and 819 sales since 2004; purchases in 9 different years, most recently 2022.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $47.5M22×22 trades |
| 2025 | — | $12.3M5×5 trades |
| 2024 | — | $24.1M25×25 trades |
| 2023 | — | $31.4M20×20 trades |
| 2022 | $19.4M10×10 trades | $26.5M12×12 trades |
| 2021 | — | $161M72×72 trades |
| 2020 | — | $50.5M42×42 trades |
| 2019 | $31K1×1 trade | $38.5M27×27 trades |
| 2018 | $5.79M2×2 trades | $90.4M52×52 trades |
| 2017 | $60M12×12 trades | $72.5M39×39 trades |
| 2016 | $319K1×1 trade | $2.34B68×68 trades |
| 2015 | — | $155M57×57 trades |
| 2014 | $750K1×1 trade | $4.54B79×79 trades |
| 2013 | — | $15.5B81×81 trades |
| 2012 | $2.15M3×3 trades | $4.58B37×37 trades |
| 2011 | $74M64×64 trades | $5.49B142×142 trades |
| 2009 | $825K1×1 trade | — |
| 2006 | — | $7.67M36×36 trades |
| 2004 | — | $56K3×3 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
People read HCA Healthcare's Wikipedia article about 270 times a day over the last week, close to the 300 on a usual day of the three months before.
May 14, 2026Busiest day: 3,400 views on May 15, 2026Nov 18, 2026
Views of the article HCA Healthcare, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
0 certified in FY2026 Q3, vs 1 a year earlier.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Latest annual report filed Feb 10, 2026, compared with the one filed Feb 14, 2025. Read the filing
The information set forth in Note 10 – Contingencies in the notes to the consolidated financial statements is incorporated herein by reference. In addition, the following matter is being disclosed pursuant to Item 103 of Regulation S-K because it relates to environmental regulations and the Company believes monetary sanctions could exceed $300,000.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 10, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Short sale volume: 52.7% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 56.9%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 8,323 shares (about $3.83M) were not delivered on time for settlement on Oct 14, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 39.1% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (30.0% on ATS, 9.1% with other brokers), below its 26-week average of 41.1%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: UBS ATS (14.1%), SIGMA X2 (12.1%), INTELLIGENT CROSS LLC (10.9%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Last results
Oct 27, 2026
Within the 30 days after it, until Nov 26, 2026
Next results, expected
Jan 25, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
100%
11 of 11 insider purchases since 2018 came within 30 days after a results announcement
From HCA Healthcare's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know HCA Healthcare's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Thomas F. Frist, Jr.
13D · may seek influence · Up from 31.6% · 70.5M shares · filed Nov 6, 2026
Vanguard Capital Management
13G · passive · Crossed 5% · 11.7M shares · filed Apr 30, 2026
Recent moves
Thomas F. Frist, Jr. raised its stake to 33.8% from 31.6% · Schedule 13D, 2026
Vanguard Capital Management went above 5%, with 5.25% · Schedule 13G, 2026
The Vanguard Group fell below 5% (0%) · Schedule 13G, 2026
Thomas F. Frist, Jr. went above 5%, with 31.6% · Schedule 13D, 2026
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Attention
Things to keep in mind
Records
Against the S&P 500 over the year
Since Nov 17, 2025, HCA is down 0.2% and the index fund is up 9.7%: 10 points behind the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much HCA moves
Beta 0.3 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).